26 related articles for article (PubMed ID: 36336860)
1. Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer.
Zhou Y; Li H; Zhang Y; Zhao E; Huang C; Pan X; Shu F; Liu Z; Tang N; Li F; Liao W
Cancer Lett; 2024 May; 589():216836. PubMed ID: 38556105
[TBL] [Abstract][Full Text] [Related]
2. The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-κB pathways.
Zhang J; Pu K; Bai S; Peng Y; Li F; Ji R; Guo Q; Sun W; Wang Y
J Int Med Res; 2020 Jun; 48(6):300060520925996. PubMed ID: 32529870
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma.
Guo W; Ma J; Pei T; Zhao T; Guo S; Yi X; Liu Y; Wang S; Zhu G; Jian Z; Gao T; Li C; Liao W; Shi Q
J Cell Mol Med; 2018 May; 22(5):2944-2954. PubMed ID: 29542252
[TBL] [Abstract][Full Text] [Related]
4. 20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
Ma Q; Wu F; Liu X; Zhao C; Sun Y; Li Y; Zhang W; Ju H; Wang Y
Transl Oncol; 2024 Apr; 45():101958. PubMed ID: 38663220
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer.
Lai CY; Yeh DW; Lu CH; Liu YL; Chuang YC; Ruan JW; Kao CY; Huang LR; Chuang TH
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936290
[TBL] [Abstract][Full Text] [Related]
6. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract][Full Text] [Related]
7. Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling.
Liu H; Li X; Shi Y; Ye Z; Cheng X
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540761
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
[TBL] [Abstract][Full Text] [Related]
9. High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients.
Scheiflinger A; Al-Gboore S; Jank BJ; Brkic F; Kadletz-Wanke L; Kenner L; Heiduschka G; Schnoell J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10675-10683. PubMed ID: 37308746
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase regenerating liver 3 participates in Integrinβ1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells.
Chen G; Zhang Z; Li J; Hu C; Gao D; Chen J; Zhang L; Xie X
J Gastrointest Oncol; 2023 Apr; 14(2):863-873. PubMed ID: 37201051
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
13. COMMD proteins function and their regulating roles in tumors.
You G; Zhou C; Wang L; Liu Z; Fang H; Yao X; Zhang X
Front Oncol; 2023; 13():1067234. PubMed ID: 36776284
[TBL] [Abstract][Full Text] [Related]
14. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract][Full Text] [Related]
15. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J
Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078
[TBL] [Abstract][Full Text] [Related]
16. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
Zhang C; Tian W; Meng L; Qu L; Shou C
J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
